KERALA AYURVEDA
Back to Income Statement
|
KERALA AYURVEDA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-15 Cr | ₹-1.56 Cr | ₹-0.53 Cr | ₹2.36 Cr | ₹-4.84 Cr |
What is the latest Consolidated Net Profit of KERALA AYURVEDA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹-15 Cr |
| Mar2024 | ₹-1.56 Cr |
| Mar2023 | ₹-0.53 Cr |
| Mar2022 | ₹2.36 Cr |
| Mar2021 | ₹-4.84 Cr |
How is Consolidated Net Profit of KERALA AYURVEDA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-15 Cr | Negative | |
| Mar2024 | ₹-1.56 Cr | Negative | |
| Mar2023 | ₹-0.53 Cr | Negative | |
| Mar2022 | ₹2.36 Cr | Positive | |
| Mar2021 | ₹-4.84 Cr | - | |
Compare Consolidated Net Profit of peers of KERALA AYURVEDA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KERALA AYURVEDA | ₹202.8 Cr | -0.9% | -4% | -71.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,431.0 Cr | -2.3% | 3% | 12.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,115.0 Cr | 2.9% | 22.7% | 25.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,853.0 Cr | -2.7% | 2% | 33.9% | Stock Analytics | |
| CIPLA | ₹119,158.0 Cr | 0.1% | 3% | -7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | 2.4% | -12.9% | -9.1% | Stock Analytics | |
KERALA AYURVEDA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KERALA AYURVEDA | -0.9% |
-4% |
-71.7% |
| SENSEX | 1.3% |
1% |
-2.9% |
You may also like the below Video Courses